Furthermore, using murine models of AML, Basheer et al. identified diametrically opposed roles of EZH2 during AML induction (tumor suppressor) and maintenance (oncogene) (Basheer et al., 2019). This evidence concerns the gene EZH2 and acute myeloid leukemia.